More importantly, it not only plays a significant inhibitory role in CD8+ T cells, but TIGIT was also found combating anti-tumor immunity by influencing nature kill cells (7, 8), antigen-presenting dendritic cells (1, 9), and T regulatory cells (Tregs) (10, 11). Here, CD8A is linked to neoplasm.